Home Healthcare Demand Will Spur Capacity Expansion

Published
28 May 25
Updated
15 Aug 25
AnalystConsensusTarget's Fair Value
US$6.75
4.3% overvalued intrinsic discount
15 Aug
US$7.04
Loading
1Y
35.1%
7D
3.1%

Author's Valuation

US$6.8

4.3% overvalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on08 Aug 25
Fair value Increased 17%

The consensus analyst price target for Aveanna Healthcare Holdings has increased from $5.75 to $6.07, reflecting improved revenue growth expectations and an uptick in net profit margins. What's in the News Aveanna Healthcare Holdings raised its full year 2025 revenue guidance to over $2.3 billion, up from more than $2.15 billion.